JD LYMON Group brings together consulting expertise in the areas of reimbursement, health policy, health economics, trial design, and evidence planning to help address a wide range of market access issues impacting medical device, pharmaceutical, and biologics companies. Consulting Solutions Successful market access strategies address the complex interrelationship between policy, evidence, and practice. We provide the following services to ensure your product's optimal market position: -Reimbursement landscape assessments. -Coding application development & submission. -Health economic modeling. -Evidence review and synthesis. -Trial design and analysis. -Payer & medical society strategy development. -Comprehensive evidence generation planning. Technology Solutions The eMgine HealthLogics system provides concise, actionable summaries of Medicare, Medicaid, and State Exchange policy information to help navigate the reimbursement landscape. -Key meetings and contacts are kept up to date with automated change notifications. -Customizable, product-class specific views are provided to help our clients stay on top of their competitors. -The intuitive interface is accessible via any web-enabled device including smartphones and tablets.
